Published online 9 May 2005 doi:10.1084/jem.20041967
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 10, 1523-1530
Decay-accelerating factor modulates induction of T cell immunity
Peter S. Heeger1,2,
Peter N. Lalli1,2,
Feng Lin2,
Anna Valujskikh1,
Jinbo Liu2,
Nasima Muqim2,
Yuanyuan Xu3, and
M. Edward Medof2
1 Department of Immunology, Cleveland Clinic Foundation, Cleveland, OH 44195
2 Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106
3 Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294
CORRESPONDENCE Peter S. Heeger: heegerp{at}ccf.org OR M. Edward Medof: mxm16{at}po.cwru.edu
Decay-accelerating factor (Daf) dissociates C3/C5 convertases that assemble on host cells and thereby prevents complement activation on their surfaces. We demonstrate that during primary T cell activation, the absence of Daf on antigen-presenting cells (APCs) and on T cells enhances T cell proliferation and augments the induced frequency of effector cells. The effect is factor D- and, at least in part, C5-dependent, indicating that local alternative pathway activation is essential. We show that cognate T cellAPC interactions are accompanied by rapid production of alternative pathway components and down-regulation of Daf expression. The findings argue that local alternative pathway activation and surface Daf protein function respectively as a costimulator and a negative modulator of T cell immunity and explain previously reported observations linking complement to T cell function. The results could have broad therapeutic implications for disorders in which T cell immunity is important.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Li, K., Anderson, K. J., Peng, Q., Noble, A., Lu, B., Kelly, A. P., Wang, N., Sacks, S. H., Zhou, W.
(2008). Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood
112: 5084-5094
[Abstract]
[Full Text]
-
Gueler, F., Rong, S., Gwinner, W., Mengel, M., Brocker, V., Schon, S., Greten, T. F., Hawlisch, H., Polakowski, T., Schnatbaum, K., Menne, J., Haller, H., Shushakova, N.
(2008). Complement 5a Receptor Inhibition Improves Renal Allograft Survival. J. Am. Soc. Nephrol.
19: 2302-2312
[Abstract]
[Full Text]
-
Pavlov, V., Raedler, H., Yuan, S., Leisman, S., Kwan, W.-h., Lalli, P. N., Medof, M. E., Heeger, P. S.
(2008). Donor Deficiency of Decay-Accelerating Factor Accelerates Murine T Cell-Mediated Cardiac Allograft Rejection. J. Immunol.
181: 4580-4589
[Abstract]
[Full Text]
-
Sacks, S., Zhou, W.
(2008). New Boundaries for Complement in Renal Disease. J. Am. Soc. Nephrol.
19: 1865-1869
[Abstract]
[Full Text]
-
Lalli, P. N., Strainic, M. G., Yang, M., Lin, F., Medof, M. E., Heeger, P. S.
(2008). Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood
112: 1759-1766
[Abstract]
[Full Text]
-
Varela, J. C., Imai, M., Atkinson, C., Ohta, R., Rapisardo, M., Tomlinson, S.
(2008). Modulation of Protective T Cell Immunity by Complement Inhibitor Expression on Tumor Cells. Cancer Res.
68: 6734-6742
[Abstract]
[Full Text]
-
Franchi, A., Zaret, J., Zhang, X., Bocca, S., Oehninger, S.
(2008). Expression of immunomodulatory genes, their protein products and specific ligands/receptors during the window of implantation in the human endometrium. Mol Hum Reprod
14: 413-421
[Abstract]
[Full Text]
-
Liu, J., Lin, F., Strainic, M. G., An, F., Miller, R. H., Altuntas, C. Z., Heeger, P. S., Tuohy, V. K., Medof, M. E.
(2008). IFN-{gamma} and IL-17 Production in Experimental Autoimmune Encephalomyelitis Depends on Local APC-T Cell Complement Production. J. Immunol.
180: 5882-5889
[Abstract]
[Full Text]
-
Nagaraju, K., Rawat, R., Veszelovszky, E., Thapliyal, R., Kesari, A., Sparks, S., Raben, N., Plotz, P., Hoffman, E. P.
(2008). Dysferlin Deficiency Enhances Monocyte Phagocytosis: A Model for the Inflammatory Onset of Limb-Girdle Muscular Dystrophy 2B. Am. J. Pathol.
172: 774-785
[Abstract]
[Full Text]
-
Peng, Q., Li, K., Anderson, K., Farrar, C. A., Lu, B., Smith, R. A. G., Sacks, S. H., Zhou, W.
(2008). Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood
111: 2452-2461
[Abstract]
[Full Text]
-
Lalli, P. N., Strainic, M. G., Lin, F., Medof, M. E., Heeger, P. S.
(2007). Decay Accelerating Factor Can Control T Cell Differentiation into IFN-{gamma}-Producing Effector Cells via Regulating Local C5a-Induced IL-12 Production. J. Immunol.
179: 5793-5802
[Abstract]
[Full Text]
-
Imai, M., Ohta, R., Varela, J. C., Song, H., Tomlinson, S.
(2007). Enhancement of Antibody-Dependent Mechanisms of Tumor Cell Lysis by a Targeted Activator of Complement. Cancer Res.
67: 9535-9541
[Abstract]
[Full Text]
-
Li, B., Allendorf, D. J., Hansen, R., Marroquin, J., Cramer, D. E., Harris, C. L., Yan, J.
(2007). Combined Yeast {beta}-Glucan and Antitumor Monoclonal Antibody Therapy Requires C5a-Mediated Neutrophil Chemotaxis via Regulation of Decay-Accelerating Factor CD55. Cancer Res.
67: 7421-7430
[Abstract]
[Full Text]
-
Miwa, T., Maldonado, M. A., Zhou, L., Yamada, K., Gilkeson, G. S., Eisenberg, R. A., Song, W.-C.
(2007). Decay-Accelerating Factor Ameliorates Systemic Autoimmune Disease in MRL/lpr Mice via Both Complement-Dependent and -Independent Mechanisms. Am. J. Pathol.
170: 1258-1266
[Abstract]
[Full Text]
-
Cauvi, D. M., Cauvi, G., Pollard, K. M.
(2006). Constitutive Expression of Murine Decay-Accelerating Factor 1 Is Controlled by the Transcription Factor Sp1. J. Immunol.
177: 3837-3847
[Abstract]
[Full Text]
-
Girardi, G., Yarilin, D., Thurman, J. M., Holers, V. M., Salmon, J. E.
(2006). Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. JEM
203: 2165-2175
[Abstract]
[Full Text]
-
Capasso, M., Durrant, L. G., Stacey, M., Gordon, S., Ramage, J., Spendlove, I.
(2006). Costimulation via CD55 on Human CD4+ T Cells Mediated by CD97. J. Immunol.
177: 1070-1077
[Abstract]
[Full Text]
-
Brown, K. M., Kondeatis, E., Vaughan, R. W., Kon, S. P., Farmer, C. K.T., Taylor, J. D., He, X., Johnston, A., Horsfield, C., Janssen, B. J.C., Gros, P., Zhou, W., Sacks, S. H., Sheerin, N. S.
(2006). Influence of donor C3 allotype on late renal-transplantation outcome.. NEJM
354: 2014-2023
[Abstract]
[Full Text]
-
Berger, S. P., Roos, A., Daha, M. R.
(2005). Complement and the kidney: What the nephrologist needs to know in 2006?. Nephrol Dial Transplant
20: 2613-2619
[Full Text]
-
Longhi, M. P., Sivasankar, B., Omidvar, N., Morgan, B. P., Gallimore, A.
(2005). Cutting Edge: Murine CD59a Modulates Antiviral CD4+ T Cell Activity in a Complement-Independent Manner. J. Immunol.
175: 7098-7102
[Abstract]
[Full Text]